Keywords: novo, a/s, invests, biotech, firm, corus, usa-based

Novo A/S invests in US biotech firm Corus

Article | 14 April 2003

Print This

USA-based biotechnology company Corus Pharma has successfully raised $40million in a series B preferred stock offering, which was led by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in